Wijesuriya, S.R.E.Deen, K.I.Hewavisenthi, J.Ratnayake, G.2019-02-182019-02-182003The Annual Sessions of the College of Surgeons of Sri Lanka and SAARC Surgical Care Society.2003, P. 161.http://repository.kln.ac.lk/handle/123456789/19935Free Papers Abstract, The Annual Sessions of the College of Surgeons of Sri Lanka and SAARC Surgical Care Society,13rd -17th August 2003 Kandy, Sri Lanka.INTRODUCTION: From July i 999 we have employed NAT on a selective basis in the management of rectal cancer. OBJECTIVE: To explore the value of NAT in patients with rectal cancer in the short term. To study the effect of Neo Adjuvant Therapy for rectal carcinoma in the short term. METHODS: Two abdomino perineal resections and 24 anterior resections were done in the NAT group and 5 and 2 l in the no NAT group. There were 2 perioperative deaths in NAT group and one in the no NAT group (P 0.75). There were 7 Cancer related deaths in the NAT group and 6 in the no NAT group (P = l). The survival was 15 month (5 -45) for the NAT group and 16 (3 -54) for the non NAT group (P = I). There were no difference in the recurrences (2 vs 4 P ""0.67) metastasis (4 vs 4 P = 1) or complication (8 vs 2 p =0.08) abdomino perineal resections were performed in 2 patients in the NAT group and 5 in the no NAT group. Anterior resections were performed in 24 patients and 24 patients in NAT and no NAT groups. CONCLUSION: Overall there was no significant difference in the clinical out come between those given NAT and those not given.enneo-adjuvant therapyConference abstract